MedPath

HAFIZ MUHAMMAD ASIF

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Evaluation of Polyherbal Coded Formulation Obesecure for Leptin Regulation and Obesity Management

Phase 2
Completed
Conditions
Leptin Deficiency
Obesity
Interventions
First Posted Date
2020-06-23
Last Posted Date
2020-06-23
Lead Sponsor
Hafiz Muhammad Asif
Target Recruit Count
132
Registration Number
NCT04443790
Locations
🇵🇰

clinical trial was conducted in Karachi,Islamabad and Faisalabad, Karachi, Punjab, Pakistan

Quadruple and Phytomedicine-based Therapies in H. Pylori Infection

Phase 2
Completed
Conditions
Helicobacter Pylori [H. Pylori] as the Cause of Diseases
Interventions
Drug: Quadruple Allopathic therapy
Drug: Pylorex plus
First Posted Date
2013-12-09
Last Posted Date
2013-12-09
Lead Sponsor
Hafiz Muhammad Asif
Target Recruit Count
176
Registration Number
NCT02004197
Locations
🇵🇰

Shifa Ul MUlk Memorial Hospital, Karachi, Pakistan

🇵🇰

clinical trial was conducted in high risk areas of Pakistan such as Karachi, Bahawalpur, Islamabad and Rawalpindi at Shifa-Ul-Mulk Memorial Hospital, Hamdrad University Karachi, Bahawalpur Victoria Hospital and Nawaz Salik Hospital respectively, Karachi, Pakistan

© Copyright 2025. All Rights Reserved by MedPath